Layer3.news

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq558qhzt7d90naq87rfpt883p4fzsxrpzhxjhzg68qs5uq5k0y4ts6a8dju

ELI LILLY SAYS WEIGHT-LOSS PILL A CANDIDATE FOR SPEEDY APPROVAL UNDER NEW US PROGRAM

https://media.zenfs.com/en/reuters.com/f8818ab602bc961cc9afba2d9de3d284

✍️ Eli Lilly's experimental weight-loss pill, orforglipron, meets most criteria for the FDA's national priority voucher, suggesting a strong candidate for accelerated approval review.

👉 Eli Lilly's experimental weight-loss pill, orforglipron, meets most criteria for the FDA's national priority voucher 👉 The company will submit its review package to the FDA this quarter 👉 The pill was shown to help patients lose 12.4% of their body weight in a late-stage study 👉 Lilly has pumped billions of dollars into new U.S. plants to manufacture the pill 👉 The company raised its full-year profit and revenue forecasts due to strong overseas demand

-- #DaveRicks #KevinGade #CarterGould #ChrisSchott #U.S. #India #NewYork #Bengaluru #health

Loading quoted post…

Dave Ricks Kevin Gade Carter Gould Chris Schott U.S.India New York Bengaluru

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq52lr9uenufw9wshzgjw6evwcn69ec5s7mtsgdp4da0uwl6277p7q2ea7cj

ELI LILLY SAYS WEIGHT-LOSS PILL A CANDIDATE FOR SPEEDY APPROVAL UNDER NEW US PROGRAM

https://media.zenfs.com/en/reuters.com/cd0363072e2572990556742df0c02630

✍️ Eli Lilly's experimental weight-loss pill, orforglipron, meets most criteria for the US FDA's new national priority voucher, suggesting a strong candidate for accelerated approval review.

👉 Eli Lilly's experimental weight-loss pill, orforglipron, meets most criteria for the US FDA's new national priority voucher 👉 The company will submit its review package to the FDA this quarter 👉 Lilly raised its full-year profit and revenue forecasts due to strong overseas demand for weight-loss drugs from cash payers 👉 Mounjaro sales came in nearly $1 billion above analysts' estimates for the quarter

-- #MrinalikaRoy #PatrickWingrove #KevinGade #DaveRicks #ChrisSchott #CarterGould #Bengaluru #NewYork #U.S. #India #business

Loading quoted post…

Mrinalika Roy Patrick Wingrove Kevin Gade Dave Ricks Chris Schott Carter Gould Bengaluru New York

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq7z08526h7e9j6wf3p34r8zyzserlaau3zw4552e802ptdxw2dsxs59wp26

ELI LILLY RAISES FORECASTS ON SURGING DEMAND FOR WEIGHT-LOSS DRUGS

https://media.zenfs.com/en/reuters.com/91860401ea10418f3efc9787119b1eb5

✍️ Eli Lilly raised its full-year profit and revenue forecasts due to strong demand for its weight-loss and diabetes drugs Zepbound and Mounjaro.

👉 Eli Lilly raised its full-year profit and revenue forecasts 👉 Strong demand for weight-loss and diabetes drugs Zepbound and Mounjaro 👉 Zepbound posted sales of $3.6 billion, beating estimates 👉 Lilly's CEO cited demand for incretin drugs as the reason for strong performance 👉 Company expects to earn $23.00 to $23.70 per share on an adjusted basis this year

-- #DaveRicks #DonaldTrump #MrinalikaRoy #SaumyadebChakrabarty #Bengaluru #UnitedStates #business

Loading quoted post…

Dave Ricks Donald Trump Mrinalika Roy Saumyadeb Chakrabarty Bengaluru United States business mainstream:perspective

10/31/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq24d6alf9du0lhmuh8m8g46qufxw0ju2pdhqegjscvled3h9ng9vsfdmvuz

ELI LILLY SAYS WEIGHT-LOSS PILL A CANDIDATE FOR SPEEDY APPROVAL UNDER NEW US PROGRAM

https://media.zenfs.com/en/reuters.com/e0522b61e9a3aef722cc94125a2fcbaf

✍️ Eli Lilly's experimental weight-loss pill, orforglipron, has met most criteria for the FDA's national priority voucher, suggesting a strong candidate for accelerated approval review.

👉 Lilly's experimental weight-loss pill, orforglipron, meets most criteria for the FDA's national priority voucher 👉 Lilly will submit its review package to the FDA this quarter 👉 Lilly raised its full-year profit and revenue forecasts due to strong overseas demand for weight-loss drugs 👉 Lilly's GLP-1 pill was shown to help patients lose 12.4% of their body weight in a late-stage study 👉 Lilly has pumped billions of dollars into new U.S. plants to manufacture the pill

-- #DaveRicks #KevinGade #CarterGould #ChrisSchott #Bengaluru #NewYork #U.S. #India #health

Loading quoted post…

Dave Ricks Kevin Gade Carter Gould Chris Schott Bengaluru New York U.S.India

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq9830mwvmnn6ca0h3ke0elmj70rf5k0pnychsjr67ezgads203clqj6cted

ELI LILLY RAISES FORECASTS ON SURGING INTERNATIONAL DEMAND FOR WEIGHT-LOSS DRUGS

https://media.zenfs.com/en/reuters.com/8d2e75cbd01357e0978d9d0a9477c476

✍️ Eli Lilly raised its full-year profit and revenue forecasts as strong demand for weight-loss and diabetes drugs helped it beat Wall Street's third-quarter earnings expectations.

👉 Eli Lilly raised its full-year profit and revenue forecasts 👉 Strong demand for weight-loss and diabetes drugs 👉 Zepbound and Mounjaro sales topped estimates 👉 Company expects adjusted earnings of $23.00 to $23.70 per share for the full year 👉 Annual revenue projected to come in at $63 billion to $63.5 billion

-- #DaveRicks #KevinGade #CarterGould #ChrisSchott #WhiteHouse #Bengaluru #NewYork #Indianapolis #business

Loading quoted post…

Dave Ricks Kevin Gade Carter Gould Chris Schott White House Bengaluru New York Indianapolis

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqreu4h7y6hhhzmgdlrc3n2gl88x9lz02azp8e68uvkkq8xua268csp6qz9y

ELI LILLY RAISES FORECASTS ON SURGING DEMAND FOR WEIGHT-LOSS, DIABETES DRUGS

https://media.zenfs.com/en/reuters.com/83b29563770b8e94f75965982449c189

✍️ Eli Lilly raises full-year profit and revenue forecasts due to strong demand for its weight-loss and diabetes drugs Zepbound and Mounjaro.

👉 Eli Lilly raises full-year profit and revenue forecasts 👉 Strong demand for weight-loss and diabetes drugs Zepbound and Mounjaro 👉 Zepbound sales exceed analysts' estimates at $3.6 billion 👉 Mounjaro sales come in at $6.5 billion, above analysts' average expectation 👉 Company's CEO credits continued demand for incretin portfolio

-- #DaveRicks #ChrisSchott #DonaldTrump #Bengaluru #UnitedStates #business

Loading quoted post…

Dave Ricks Chris Schott Donald Trump Bengaluru United States business mainstream:perspective

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqh85r5kqsy2gkxr9qewjzs5056vzv4g7u8sfcdwrmpknuw793ln9qqk885u

ELI LILLY, NVIDIA PARTNER TO BUILD SUPERCOMPUTER, AI FACTORY FOR DRUG DISCOVERY AND DEVELOPMENT

https://image.cnbcfm.com/api/v1/image/108203000-17586586822025-09-23t201605z_1719661872_rc2oxga1dwo0_rtrmadp_0_usa-lilly.jpeg?v=1758658848&w=1920&h=1080

✍️ Eli Lilly and Nvidia are partnering to build a powerful supercomputer and AI factory to accelerate drug discovery and development, aiming to bring new medicines to patients faster and reduce costs.

👉 Eli Lilly and Nvidia are partnering to build a powerful supercomputer and AI factory 👉 The supercomputer will be powered by over 1,000 Blackwell Ultra GPUs connected on a unified, high-speed network 👉 The AI factory will develop, train, and deploy AI models at scale for drug discovery and development 👉 The partnership aims to accelerate drug discovery and development, reducing costs and bringing new medicines to patients faster

-- #DaveRicks #DiogoRau #ThomasFuchs #KimberlyPowell #Houston,Texas,U.S. #technology

Loading quoted post…

Dave Ricks Diogo Rau Thomas Fuchs Kimberly Powell Houston, Texas, U.S.technology mainstream:perspective

10/28/2025

nostr:nevent1qvzqqqqqqypzp8fng5y4axrdakd0wfxjd2x9hms9p07kzhpjl308dxq6pzw8yqywqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq4sk7s6r4zrnjuram5kz5t47rk8445c4fuxcs42r56kwyyhn7c2wqgahv2g

MODERNA BOSS DEFENDS UK IN DRUG-PRICING ROW AS HE OPENS £150M OXFORDSHIRE FACILITY

https://i.guim.co.uk/img/media/d7cbd0ec0384889448f2ab7ac96ced6b27071d08/885_0_4423_3539/master/4423.jpg?width=140&quality=85&auto=format&fit=max&s=8928ac7b2d02acaa2ee79530e3347faf

✍️ The UK boss of Moderna, a US drugmaker, defends the country's drug pricing policies after being labelled the 'worst in Europe' by other pharmaceutical executives.

👉 Moderna's UK general manager defends the country's drug pricing policies 👉 The company opens a £150m vaccine site in Oxfordshire 👉 Moderna's peers announce plans to pause or ditch investments in the UK due to pricing concerns 👉 The company's new centre will produce mRNA vaccines for the NHS's seasonal vaccination programs 👉 Moderna will research new applications for mRNA technology

-- #DariusHughes #DaveRicks #StéphaneBancel #PatrickVallance #Oxfordshire #Harwell #UK #health

Loading quoted post…

Darius Hughes Dave Ricks Stéphane Bancel Patrick Vallance Oxfordshire Harwell UK health

nostr:nevent1qvzqqqqqqypzp8fng5y4axrdakd0wfxjd2x9hms9p07kzhpjl308dxq6pzw8yqywqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqwmrvw0c29wpesjwa9w6s82dewjw5gfmgt2d2ae2d0gtyerpty0ssjhyue2

BT BOSS SAYS COSTS ‘INFLICTED’ BY UK ARE 10 TIMES THOSE FACED BY EUROPEAN SECTOR

https://i.guim.co.uk/img/media/de490662ea64fd8337ddc9843578eabae19e2d1f/332_0_3335_2668/master/3335.jpg?width=140&quality=85&auto=format&fit=max&s=a63fd6181882f1ca10d15b4953238118

✍️ BT's CEO Allison Kirkby has criticized the UK government's high costs for telecoms operators, stating that they pay 10 times more than their European peers.

👉 BT's CEO Allison Kirkby has criticized the UK government's high costs for telecoms operators 👉 Telecoms operators in the UK pay 10 times more in 'government-inflicted costs' compared to their European peers 👉 Kirkby warned that the November budget could be 'very difficult' for the UK Chancellor Rachel Reeves 👉 Planning reforms are needed to make it easier to roll out large-scale infrastructure projects

-- #AllisonKirkby #RachelReeves #PhilipJansen #DaveRicks #CSVenkatakrishnan #UK #Germany #Netherlands #London #business

Loading quoted post…

Allison Kirkby Rachel Reeves Philip Jansen Dave Ricks CS Venkatakrishnan UK Germany Netherlands

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq4gq9j6gts74x3d2eg6d34a2fsk25957cctupw0ww0fucte0y8h5srmrm3m

ELI LILLY TO BUILD $5 BILLION VIRGINIA FACILITY TO BOOST PRODUCTION OF TARGETED CANCER DRUGS, OTHER TREATMENTS

https://image.cnbcfm.com/api/v1/image/108184894-17550206822025-08-12t173750z_397057516_rc26lz9i31dr_rtrmadp_0_usa-texas-eli-lilly.jpeg?v=1755020703&w=1920&h=1080

✍️ Eli Lilly to spend $5 billion to build a manufacturing facility in Virginia to boost production capacity for targeted cancer drugs and other treatments.

👉 Eli Lilly to spend $5 billion to build a manufacturing facility in Virginia 👉 Facility will develop active ingredients for cancer and autoimmune drugs 👉 Will bring over 650 new jobs to Virginia 👉 Part of a larger plan to build four new domestic manufacturing plants 👉 Remaining three sites to be announced later this year

-- #DaveRicks #DonaldTrump #Virginia #SanDiego #California #GoochlandCounty #business

Loading quoted post…

Dave Ricks Donald Trump Virginia San Diego California Goochland County business mainstream:perspective

9/16/2025

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqd824vhure8pmng5vjtl4fwgfk5af4vhknjp30kjrr37zttp4fx6svtnrge

1 SUPER STOCK DOWN MORE THAN 20% TO BUY HAND OVER FIST, ACCORDING TO WALL STREET

https://s.yimg.com/ny/api/res/1.2/AqsBu6Xbj0w5TEmrPNiJeQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTM-/https://media.zenfs.com/en/motleyfool.com/11c2ca44d50b7069dc7c27ef9a6104b2

✍️ Eli Lilly's stock has fallen due to increasing competition and concerns about its obesity drug market, but Wall Street remains bullish about the pharma stock.

👉 Increasing competition in the obesity drug market 👉 Concerns about recent quarterly updates 👉 Potential implementation of steep tariffs on pharmaceutical imports 👉 Analysts remain optimistic about Eli Lilly's future 👉 Mounjaro and Zepbound still have significant sales growth potential

-- #DaveRicks #KeithSpeights #business

Loading quoted post…

Dave Ricks Keith Speights business mainstream:perspective

9/12/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqyrcjypgp9yv3w2450vxsusjwln7fs8qz73lv68vmft3yj85z5haqu0vpez

ELI LILLY AND COMPANY (LLY) NEEDS TO GET A WEIGHT LOSS PILL OUT, SAYS JIM CRAMER

https://media.zenfs.com/en/insidermonkey.com/4297bceadd7b3662bc208031885247f5

✍️ Jim Cramer discusses Eli Lilly and Company's (NYSE:LLY) potential in the weight loss drug industry, citing its robust drug pipeline and aggressive manufacturing investments.

👉 Eli Lilly and Company (NYSE:LLY) has a strong presence in the weight loss drug industry 👉 The company has a robust drug pipeline 👉 Eli Lilly and Company (NYSE:LLY) is making aggressive manufacturing investments 👉 The company's weight loss pill has the potential to benefit significantly

-- #JimCramer #DaveRicks #JeffMarks #business

Loading quoted post…

Jim Cramer Dave Ricks Jeff Marks business mainstream:perspective

8/31/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqu7nuyl8l4u4j637qjmggwaarqq7tes4nmley3z46ecv5pr35vlqsw7rylh

WHY ELI LILLY STOCK IS PLUNGING TODAY

https://s.yimg.com/ny/api/res/1.2/jFL92E8CPyCwKntOjxCeCw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MzM-/https://media.zenfs.com/en/motleyfool.com/d9d6e36d87fa920d0a54c1e4c8b62a65

✍️ Eli Lilly's stock plummeted 14.8% after announcing mixed results from a phase 3 study of its oral GLP-1 agonist, orforglipron, which achieved less weight loss than expected and had a relatively high patient discontinuation rate.

👉 Eli Lilly's stock fell 14.8% after announcing mixed results from a phase 3 study of orforglipron 👉 Orglipron achieved less weight loss than expected, with patients receiving the 36 mg dose experiencing an average weight loss of 12.4% 👉 The high patient discontinuation rate of 10.3% raised concerns 👉 CEO Dave Ricks expressed optimism about the drug's potential, citing its potential appeal to patients and physicians

-- #DaveRicks #business

Loading quoted post…

Dave Ricks business mainstream:perspective

8/9/2025

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqv62ny5jpg2q2m7vph9k4ze64yc8r3llaj523ppp53vkukx7yzkvsvv6qpz

WHERE ELI LILLY STANDS AFTER Q2 BEAT BUT WEAK GLP-1 PILL DATA

https://s.yimg.com/ny/api/res/1.2/6PMhNzXCU5wS6nxTgaa8Uw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://s.yimg.com/os/creatr-uploaded-images/2025-08/23851150-7395-11f0-bb9d-a87c630d4ee2

✍️ Eli Lilly raises full-year forecast after beating Q2 expectations, but its weight-loss pill Orforglipron shows 11% weight loss and 24% dropout rate at highest dose, weighing on shares.

👉 Eli Lilly raises full-year forecast after beating Q2 expectations 👉 Orgforglipron shows 11% weight loss, but 24% dropout rate at highest dose 👉 CEO emphasizes importance of addressing most favored nations issue

-- #AnjaleeKhemlani #AngeliCamalani #DaveRicks #EvanSeegerman #business

Loading quoted post…

Anjalee Khemlani Angeli Camalani Dave Ricks Evan Seegerman business mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqp9rg774jhzs4rw4wmejypedptl3pk34wz80hdxxnjghy2amm8qxsgsxa5t

ELI LILLY SECOND QUARTER EARNINGS BEAT ON STRONG GLP-1 SALES, BUT STOCK DIVES ON GLP-1 PILL TRIAL RESULTS

https://s.yimg.com/ny/api/res/1.2/MwywwZOTU4FpEEiAYybdaw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2025-04/9f779d70-25ff-11f0-b6f7-9778a735cf34

✍️ Eli Lilly reported better-than-expected earnings for the second quarter, but its oral GLP-1 pill failed to meet expectations, causing the stock to drop 13%.

👉 Eli Lilly reported better-than-expected earnings for the second quarter 👉 The company's oral GLP-1 pill, orforglipron, failed to meet expectations 👉 GLP-1 drugs, Mounjaro and Zepbound, drove growth 👉 Zepbound overtakes Novo Nordisk's Wegovy in prescriptions

-- #DaveRicks #JaredHolz #AnjaleeKhemlani #business

Loading quoted post…

Dave Ricks Jared Holz Anjalee Khemlani business mainstream:perspective

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqf3jd5s7adgjwfjhglg97syl3ycsnsen6cvnaju47r3csrn72edls9cqdsg

ELI LILLY BEATS EARNINGS FOR SECOND QUARTER ON STRONG GLP-1 SALES, BUT STOCK DIVES ON GLP-1 PILL TRIAL RESULTS

https://s.yimg.com/ny/api/res/1.2/MwywwZOTU4FpEEiAYybdaw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2025-04/9f779d70-25ff-11f0-b6f7-9778a735cf34

✍️ Eli Lilly reported better-than-expected earnings for the second quarter, driven by strong sales of its GLP-1s, but its oral pill GLP-1, orforglipron, disappointed in late-stage trials.

👉 Eli Lilly reported better-than-expected earnings for the second quarter 👉 Strong sales of GLP-1s, including Mounjaro and Zepbound, drove revenue growth 👉 Oral pill GLP-1, orforglipron, disappointed in late-stage trials with a 25% patient drop-out rate 👉 Zepbound has overtaken competitor Novo Nordisk's Wegovy in the GLP-1 space 👉 Lilly expects FDA decision on orforglipron by next year

-- #DaveRicks #JaredHolz #AnjaleeKhemlani #business

Loading quoted post…

Dave Ricks Jared Holz Anjalee Khemlani business mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq992pusdu2e3kpyjj7ytltfl5zfmht2g8efdp2f7v7eltvg5vvgvq3g4qtx

CAN ELI LILLY STOCK WITHSTAND THE THREAT OF PRESIDENT TRUMP'S NEW SWEEPING TARIFFS?

https://s.yimg.com/ny/api/res/1.2/T.P6dcpe2sLRBOnVcZWnZQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/0335549b1e002a7277f6e7305a63eb91

✍️ President Trump has threatened to impose tariffs of up to 200% on pharmaceutical imports, which could negatively affect Eli Lilly's margins. However, the company's CEO believes the impact will be temporary.

👉 President Trump has threatened to impose tariffs of up to 200% on pharmaceutical imports 👉 Eli Lilly's CEO believes the impact will be temporary 👉 Lilly is planning to build up its U.S. operations to supply all products sold in the U.S. from U.S. manufacturing facilities 👉 Analysts at Barclays and UBS agree that tariffs could significantly hurt drugmakers' margins on products manufactured outside the U.S. 👉 Lilly has three options to navigate the tariffs: relocate manufacturing to the U.S., pass higher prices along to customers, or absorb the higher costs

-- #PresidentTrump #DaveRicks #HowardLutnick #UnitedStates #Ireland #business

Loading quoted post…

President Trump Dave Ricks Howard Lutnick United States Ireland business mainstream:perspective

7/19/2025

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqs4fyxy5rh6a9zw064kkatkjnk5twq7fdt0u0706q89ath4yt50tsujmntc

NOVO NORDISK IS BETTING ON A CEO SHAKEUP TO REGAIN ITS WEIGHT LOSS DRUG EDGE OVER ELI LILLY

https://image.cnbcfm.com/api/v1/image/107384912-17099193952024-03-08t163656z_688503029_rc2nh6akn9wi_rtrmadp_0_novo-nordisk-strategy.jpeg?v=1709919495&w=1920&h=1080

✍️ Novo Nordisk's CEO steps down as the company struggles to regain its lead in the weight loss drug market, with Eli Lilly's rival treatment gaining ground.

👉 Novo Nordisk's CEO, Lars Fruergaard Jorgensen, is stepping down 👉 Wegovy loses ground to Eli Lilly's rival treatment, Zepbound 👉 Novo Nordisk is banking on fresh leadership to help it reclaim its position in the market 👉 Company is ceding market share to Eli Lilly 👉 New CEO will need to navigate challenges of launching new weight loss drugs 👉 Manage impact of Medicare drug price negotiations and President Trump's planned tariffs on pharmaceuticals

-- #LarsFruergaardJorgensen #DaveRicks #EvanSeigerman #CourtneyBreen #HelgeLund #Copenhagen #Denmark #UnitedStates #health

Loading quoted post…

Lars Fruergaard Jorgensen Dave Ricks Evan Seigerman Courtney Breen Helge Lund Copenhagen Denmark United States

5/19/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqulhut4lakuvyfct2gqa6036xfgdlrcqm8y0c5jejg4mnxhnwfskqpwhul4

JIM CRAMER SAYS ELI LILLY AND COMPANY (LLY) CEO DAVID RICKS IS ‘VERY CONSERVATIVE’

https://s.yimg.com/ny/api/res/1.2/UjoPACeXPFyN.4G.yM_TTw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/860932d32d923713fdffa5b1d444d8a3

✍️ Jim Cramer discusses AI and its impact on the stock market, mentioning Eli Lilly and Company (NYSE:LLY) as one of his favorite pharmaceutical and healthcare stocks.

👉 Eli Lilly and Company (NYSE:LLY) is one of Jim Cramer's favorite pharmaceutical and healthcare stocks 👉 Jim Cramer believes that AI is back and that the US has superior technology compared to China 👉 The US AI chip sanctions have restricted sales of advanced AI chips to China 👉 Cramer believes that Eli Lilly and Company (NYSE:LLY) has a strong non-weight loss drug portfolio and manufacturing investments

-- #JimCramer #DavidFaber #DaveRicks #JensenHuang #China #UnitedStates #EU #Iceland #Mexico #technology

Loading quoted post…

Jim Cramer David Faber Dave Ricks Jensen Huang China United States EU Iceland

5/7/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqpgzsx62kmzlwgfrz42qcfnnv05hrzplrqr6n4934qnhlx53wevnqra6xmc

ELI LILLY DOWNPLAYS CVS MOVE TO DROP ZEPBOUND COVERAGE, SHARES PLUNGE

https://media.zenfs.com/en/reuters-finance.com/d24b443d01b743295bfe04b1025ecb1e

✍️ Eli Lilly's shares fell 10% after CVS Health decided to drop the company's obesity drug Zepbound from some lists of medicines it covers for reimbursement.

👉 CVS Health's pharmacy benefit management unit will drop Zepbound coverage from July 1 👉 Lilly's shares fell 10% after the announcement 👉 Zepbound's prescription growth has surged ahead of Novo Nordisk's rival GLP-1 weight-loss drug Wegovy in recent months 👉 Lilly CEO Dave Ricks said most customers affected by CVS's move would be smaller employers that do not tend to cover obesity drugs

-- #DaveRicks #DavidJoyner #DanielBarasa #DavidRisinger #Bengaluru #NewYork #business

Loading quoted post…

Dave Ricks David Joyner Daniel Barasa David Risinger Bengaluru New York business mainstream:perspective

5/2/2025

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqk68lez9ne24sx7tk3sd6ce023ewwda7w6jf2assu5hcg6xtferks2frsth

ELI LILLY CEO SAYS COMPANY CAN HELP 'RESPOND' TO NATIONAL SECURITY CONCERNS AROUND ESSENTIAL DRUGS AS TARIFFS LOOM

https://image.cnbcfm.com/api/v1/image/108139274-1746103037690-gettyimages-2078688905-yale390482_nqf77adz.jpeg?v=1746103055&w=1920&h=1080

✍️ Eli Lilly CEO Dave Ricks expressed concerns about national security concerns around cheaper essential medicines and the potential impact of pharmaceutical tariffs on the industry.

👉 Eli Lilly CEO Dave Ricks expressed concerns about national security concerns around cheaper essential medicines 👉 The company is willing to talk to the administration about how to respond to a crisis 👉 Older generic drugs account for about 90% of medicines prescribed in the US 👉 Pharmaceutical tariffs may lead to shortages of certain generic drugs 👉 Eli Lilly is investing $27 billion to build four new production sites in the US 👉 Permanent lower tax rates in the US are needed, particularly 15% for domestic production

-- #DaveRicks #DonaldTrump #AlbertBourla #NewYorkCity #India #China #Ireland #Singapore #Switzerland #US #business

Loading quoted post…

Dave Ricks Donald Trump Albert Bourla New York City India China Ireland Singapore

5/1/2025

npub1hyh2zn8…ncvnzp

WEIGHT-LOSS CRAZE SPARKS A DC LOBBYING BONANZA

https://static.politico.com/1a/26/65e46c854517b7ed3036787de74d/main-lippman-weightlossdrugs-illustration.jpg

✍️ President Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare should cover them, with pharma companies and telehealth platforms lobbying for their interests.

👉 Pharma companies and telehealth platforms are lobbying for access to anti-obesity drugs 👉 The Trump administration is under pressure to decide how widely available the medications should be and whether Medicare should cover them 👉 The issue is complex, with concerns about cost, safety, and access to the medications 👉 Pharma companies are promoting the safety and effectiveness of their FDA-approved products 👉 Telehealth platforms are promoting the availability and affordability of their compounded products

-- #DonaldTrump #RobertF.KennedyJr. #SeanSpicer #MehmetOz #ElonMusk #DaveRicks #GregD'Angelo #Washington #Europe #health

Loading quoted post…

nostr:nevent1qvzqqqqqqypzpwfw59x0wkzthr52tx7k4su4gfmzuedhgsue5cdfev7pe7qxqmrhqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqthlpw6que4fe8cztpjfexza8pung55k3e42pw77k56j0wcqu77gsuw7azj

Donald Trump Robert F. Kennedy Jr.Sean Spicer Mehmet Oz Elon Musk Dave Ricks Greg D'Angelo Washington

4/27/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqt42aeln85y78nkeujawq2t8d0ms3nhwwgqznpvz7080defxcke3qj3nlpv

ANALYSIS-PHARMA COMPANIES EXPECTED TO ABSORB ANY TARIFF HIT IN SHORT TERM

https://media.zenfs.com/en/reuters-finance.com/db3453d8c7ca463c4dcab71f62447088

✍️ The US tariffs on pharmaceuticals may lead to higher prices for brand-name medicines, but in the short term, the costs are likely to be absorbed by drugmakers rather than patients.

👉 US tariffs on pharmaceuticals may lead to higher prices for brand-name medicines 👉 In the short term, the costs are likely to be absorbed by drugmakers rather than patients 👉 The tariffs are part of a national security investigation into pharmaceuticals to boost domestic manufacturing 👉 The industry has been lobbying for phased-in tariffs 👉 Lower-margin, generic drugs are at risk of being affected by the tariffs

-- #DeenaBeasley #MelissaBarber #RobinFeldman #BillCoyle #DaveRicks #WilliamPadula #US #YaleUniversity #India #China #EuropeanUnion #Ireland #UnitedStates #health

Loading quoted post…

Deena Beasley Melissa Barber Robin Feldman Bill Coyle Dave Ricks William Padula US Yale University

4/16/2025

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq4udj6hvxjta2jlm5k6t8d6frfeacx48ptje6n43862azjqvqzhmsnm7pca

TRUMP'S PHARMACEUTICAL TARIFFS COULD RAISE COSTS FOR PATIENTS, WORSEN DRUG SHORTAGES

https://image.cnbcfm.com/api/v1/image/105349029-1532439541748gettyimages-501415374.jpeg?v=1743629970&w=1920&h=1080

✍️ President Trump's planned tariffs on pharmaceuticals could disrupt the global supply chain, drive up drug prices, and exacerbate shortages of critical medicines, experts warn.

👉 Tariffs could disrupt the global pharmaceutical supply chain 👉 Prices of drugs in the U.S. could increase 👉 Shortages of critical medicines could worsen 👉 Some drugmakers may be better positioned to weather tariffs due to domestic manufacturing presence 👉 Generic drugmakers may struggle to absorb higher costs

-- #DonaldTrump #MarianaSocal #SteveScala #ArdaUral #MartaWosińska #DaveRicks #UnitedStates #Europe #China #India #health

Loading quoted post…

Donald Trump Mariana Socal Steve Scala Arda Ural Marta Wosińska Dave Ricks United States Europe

4/11/2025

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq4285enqczs0rsujz8w09yl7r4az5f6ghmg5xzwsq3awsuk0ddu5sxhlv05

PHARMACEUTICAL STOCKS FALL AS TRUMP DOUBLES DOWN ON TARIFFS THREAT

https://image.cnbcfm.com/api/v1/image/107386526-17102774692023-03-01t183627z_95571214_rc24lz9u1qcj_rtrmadp_0_lilly-insulin.jpeg?v=1738097880&w=1920&h=1080

✍️ President Trump's plan to impose tariffs on pharmaceuticals imported into the U.S. led to a decline in shares of drugmakers, with U.S.-based companies falling 4% or more and foreign-based companies falling more than 4%.

👉 President Trump plans to impose tariffs on pharmaceuticals imported into the U.S. 👉 Shares of drugmakers fell, with U.S.-based companies dropping 4% or more and foreign-based companies falling more than 4% 👉 Analysts and companies have raised concerns about the difficulty and cost of reshoring production 👉 Companies have pushed back on the tariffs, warning about their potential impact on research and development and patients

-- #DonaldTrump #EvanSeigerman #DaveRicks #SanDiego #California #NewYork #China #India #politics

Loading quoted post…

Donald Trump Evan Seigerman Dave Ricks San Diego California New York China India

4/9/2025

Layer3.news

AI by layer3.news

Filtering by: Dave Ricks · clear filter

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqergyc9x7yy6lemc8u8y8zjqpytc6w4e5thxktwrhkrudpp9fy7fsrawvel

ELI LILLY’S (LLY) “A GREAT COMPANY,” SAYS JIM CRAMER

https://s.yimg.com/ny/api/res/1.2/xte9MhZL4e8gerPE_iJy3Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/insidermonkey.com/290fa440a8a1f8d847914eda53dc1026

✍️ Jim Cramer praises Eli Lilly and Company's manufacturing initiatives and potential for weight loss pill, but notes that some AI stocks may hold greater promise.

-- #JimCramer #KenLangone #DaveRicks #Trump #business

Loading quoted post…

Jim Cramer Ken Langone Dave Ricks Trump business mainstream:perspective

11/15/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq558qhzt7d90naq87rfpt883p4fzsxrpzhxjhzg68qs5uq5k0y4ts6a8dju

ELI LILLY SAYS WEIGHT-LOSS PILL A CANDIDATE FOR SPEEDY APPROVAL UNDER NEW US PROGRAM

https://media.zenfs.com/en/reuters.com/f8818ab602bc961cc9afba2d9de3d284

✍️ Eli Lilly's experimental weight-loss pill, orforglipron, meets most criteria for the FDA's national priority voucher, suggesting a strong candidate for accelerated approval review.

-- #DaveRicks #KevinGade #CarterGould #ChrisSchott #U.S. #India #NewYork #Bengaluru #health

Loading quoted post…

Dave Ricks Kevin Gade Carter Gould Chris Schott U.S.India New York Bengaluru

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq52lr9uenufw9wshzgjw6evwcn69ec5s7mtsgdp4da0uwl6277p7q2ea7cj

ELI LILLY SAYS WEIGHT-LOSS PILL A CANDIDATE FOR SPEEDY APPROVAL UNDER NEW US PROGRAM

https://media.zenfs.com/en/reuters.com/cd0363072e2572990556742df0c02630

✍️ Eli Lilly's experimental weight-loss pill, orforglipron, meets most criteria for the US FDA's new national priority voucher, suggesting a strong candidate for accelerated approval review.

-- #MrinalikaRoy #PatrickWingrove #KevinGade #DaveRicks #ChrisSchott #CarterGould #Bengaluru #NewYork #U.S. #India #business

Loading quoted post…

Mrinalika Roy Patrick Wingrove Kevin Gade Dave Ricks Chris Schott Carter Gould Bengaluru New York

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq7z08526h7e9j6wf3p34r8zyzserlaau3zw4552e802ptdxw2dsxs59wp26

ELI LILLY RAISES FORECASTS ON SURGING DEMAND FOR WEIGHT-LOSS DRUGS

https://media.zenfs.com/en/reuters.com/91860401ea10418f3efc9787119b1eb5

✍️ Eli Lilly raised its full-year profit and revenue forecasts due to strong demand for its weight-loss and diabetes drugs Zepbound and Mounjaro.

-- #DaveRicks #DonaldTrump #MrinalikaRoy #SaumyadebChakrabarty #Bengaluru #UnitedStates #business

Loading quoted post…

Dave Ricks Donald Trump Mrinalika Roy Saumyadeb Chakrabarty Bengaluru United States business mainstream:perspective

10/31/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq24d6alf9du0lhmuh8m8g46qufxw0ju2pdhqegjscvled3h9ng9vsfdmvuz

ELI LILLY SAYS WEIGHT-LOSS PILL A CANDIDATE FOR SPEEDY APPROVAL UNDER NEW US PROGRAM

https://media.zenfs.com/en/reuters.com/e0522b61e9a3aef722cc94125a2fcbaf

✍️ Eli Lilly's experimental weight-loss pill, orforglipron, has met most criteria for the FDA's national priority voucher, suggesting a strong candidate for accelerated approval review.

-- #DaveRicks #KevinGade #CarterGould #ChrisSchott #Bengaluru #NewYork #U.S. #India #health

Loading quoted post…

Dave Ricks Kevin Gade Carter Gould Chris Schott Bengaluru New York U.S.India

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq9830mwvmnn6ca0h3ke0elmj70rf5k0pnychsjr67ezgads203clqj6cted

ELI LILLY RAISES FORECASTS ON SURGING INTERNATIONAL DEMAND FOR WEIGHT-LOSS DRUGS

https://media.zenfs.com/en/reuters.com/8d2e75cbd01357e0978d9d0a9477c476

✍️ Eli Lilly raised its full-year profit and revenue forecasts as strong demand for weight-loss and diabetes drugs helped it beat Wall Street's third-quarter earnings expectations.

-- #DaveRicks #KevinGade #CarterGould #ChrisSchott #WhiteHouse #Bengaluru #NewYork #Indianapolis #business

Loading quoted post…

Dave Ricks Kevin Gade Carter Gould Chris Schott White House Bengaluru New York Indianapolis

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqreu4h7y6hhhzmgdlrc3n2gl88x9lz02azp8e68uvkkq8xua268csp6qz9y

ELI LILLY RAISES FORECASTS ON SURGING DEMAND FOR WEIGHT-LOSS, DIABETES DRUGS

https://media.zenfs.com/en/reuters.com/83b29563770b8e94f75965982449c189

✍️ Eli Lilly raises full-year profit and revenue forecasts due to strong demand for its weight-loss and diabetes drugs Zepbound and Mounjaro.

-- #DaveRicks #ChrisSchott #DonaldTrump #Bengaluru #UnitedStates #business

Loading quoted post…

Dave Ricks Chris Schott Donald Trump Bengaluru United States business mainstream:perspective

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqh85r5kqsy2gkxr9qewjzs5056vzv4g7u8sfcdwrmpknuw793ln9qqk885u

ELI LILLY, NVIDIA PARTNER TO BUILD SUPERCOMPUTER, AI FACTORY FOR DRUG DISCOVERY AND DEVELOPMENT

https://image.cnbcfm.com/api/v1/image/108203000-17586586822025-09-23t201605z_1719661872_rc2oxga1dwo0_rtrmadp_0_usa-lilly.jpeg?v=1758658848&w=1920&h=1080

✍️ Eli Lilly and Nvidia are partnering to build a powerful supercomputer and AI factory to accelerate drug discovery and development, aiming to bring new medicines to patients faster and reduce costs.

-- #DaveRicks #DiogoRau #ThomasFuchs #KimberlyPowell #Houston,Texas,U.S. #technology

Loading quoted post…

Dave Ricks Diogo Rau Thomas Fuchs Kimberly Powell Houston, Texas, U.S.technology mainstream:perspective

10/28/2025

nostr:nevent1qvzqqqqqqypzp8fng5y4axrdakd0wfxjd2x9hms9p07kzhpjl308dxq6pzw8yqywqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq4sk7s6r4zrnjuram5kz5t47rk8445c4fuxcs42r56kwyyhn7c2wqgahv2g

MODERNA BOSS DEFENDS UK IN DRUG-PRICING ROW AS HE OPENS £150M OXFORDSHIRE FACILITY

https://i.guim.co.uk/img/media/d7cbd0ec0384889448f2ab7ac96ced6b27071d08/885_0_4423_3539/master/4423.jpg?width=140&quality=85&auto=format&fit=max&s=8928ac7b2d02acaa2ee79530e3347faf

✍️ The UK boss of Moderna, a US drugmaker, defends the country's drug pricing policies after being labelled the 'worst in Europe' by other pharmaceutical executives.

-- #DariusHughes #DaveRicks #StéphaneBancel #PatrickVallance #Oxfordshire #Harwell #UK #health

Loading quoted post…

Darius Hughes Dave Ricks Stéphane Bancel Patrick Vallance Oxfordshire Harwell UK health

nostr:nevent1qvzqqqqqqypzp8fng5y4axrdakd0wfxjd2x9hms9p07kzhpjl308dxq6pzw8yqywqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqwmrvw0c29wpesjwa9w6s82dewjw5gfmgt2d2ae2d0gtyerpty0ssjhyue2

BT BOSS SAYS COSTS ‘INFLICTED’ BY UK ARE 10 TIMES THOSE FACED BY EUROPEAN SECTOR

https://i.guim.co.uk/img/media/de490662ea64fd8337ddc9843578eabae19e2d1f/332_0_3335_2668/master/3335.jpg?width=140&quality=85&auto=format&fit=max&s=a63fd6181882f1ca10d15b4953238118

✍️ BT's CEO Allison Kirkby has criticized the UK government's high costs for telecoms operators, stating that they pay 10 times more than their European peers.

-- #AllisonKirkby #RachelReeves #PhilipJansen #DaveRicks #CSVenkatakrishnan #UK #Germany #Netherlands #London #business

Loading quoted post…

Allison Kirkby Rachel Reeves Philip Jansen Dave Ricks CS Venkatakrishnan UK Germany Netherlands

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq4gq9j6gts74x3d2eg6d34a2fsk25957cctupw0ww0fucte0y8h5srmrm3m

ELI LILLY TO BUILD $5 BILLION VIRGINIA FACILITY TO BOOST PRODUCTION OF TARGETED CANCER DRUGS, OTHER TREATMENTS

https://image.cnbcfm.com/api/v1/image/108184894-17550206822025-08-12t173750z_397057516_rc26lz9i31dr_rtrmadp_0_usa-texas-eli-lilly.jpeg?v=1755020703&w=1920&h=1080

✍️ Eli Lilly to spend $5 billion to build a manufacturing facility in Virginia to boost production capacity for targeted cancer drugs and other treatments.

-- #DaveRicks #DonaldTrump #Virginia #SanDiego #California #GoochlandCounty #business

Loading quoted post…

Dave Ricks Donald Trump Virginia San Diego California Goochland County business mainstream:perspective

9/16/2025

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqd824vhure8pmng5vjtl4fwgfk5af4vhknjp30kjrr37zttp4fx6svtnrge

1 SUPER STOCK DOWN MORE THAN 20% TO BUY HAND OVER FIST, ACCORDING TO WALL STREET

https://s.yimg.com/ny/api/res/1.2/AqsBu6Xbj0w5TEmrPNiJeQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTM-/https://media.zenfs.com/en/motleyfool.com/11c2ca44d50b7069dc7c27ef9a6104b2

✍️ Eli Lilly's stock has fallen due to increasing competition and concerns about its obesity drug market, but Wall Street remains bullish about the pharma stock.

-- #DaveRicks #KeithSpeights #business

Loading quoted post…

Dave Ricks Keith Speights business mainstream:perspective

9/12/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqyrcjypgp9yv3w2450vxsusjwln7fs8qz73lv68vmft3yj85z5haqu0vpez

ELI LILLY AND COMPANY (LLY) NEEDS TO GET A WEIGHT LOSS PILL OUT, SAYS JIM CRAMER

https://media.zenfs.com/en/insidermonkey.com/4297bceadd7b3662bc208031885247f5

✍️ Jim Cramer discusses Eli Lilly and Company's (NYSE:LLY) potential in the weight loss drug industry, citing its robust drug pipeline and aggressive manufacturing investments.

-- #JimCramer #DaveRicks #JeffMarks #business

Loading quoted post…

Jim Cramer Dave Ricks Jeff Marks business mainstream:perspective

8/31/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqu7nuyl8l4u4j637qjmggwaarqq7tes4nmley3z46ecv5pr35vlqsw7rylh

WHY ELI LILLY STOCK IS PLUNGING TODAY

https://s.yimg.com/ny/api/res/1.2/jFL92E8CPyCwKntOjxCeCw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MzM-/https://media.zenfs.com/en/motleyfool.com/d9d6e36d87fa920d0a54c1e4c8b62a65

✍️ Eli Lilly's stock plummeted 14.8% after announcing mixed results from a phase 3 study of its oral GLP-1 agonist, orforglipron, which achieved less weight loss than expected and had a relatively high patient discontinuation rate.

-- #DaveRicks #business

Loading quoted post…

Dave Ricks business mainstream:perspective

8/9/2025

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqv62ny5jpg2q2m7vph9k4ze64yc8r3llaj523ppp53vkukx7yzkvsvv6qpz

WHERE ELI LILLY STANDS AFTER Q2 BEAT BUT WEAK GLP-1 PILL DATA

https://s.yimg.com/ny/api/res/1.2/6PMhNzXCU5wS6nxTgaa8Uw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://s.yimg.com/os/creatr-uploaded-images/2025-08/23851150-7395-11f0-bb9d-a87c630d4ee2

✍️ Eli Lilly raises full-year forecast after beating Q2 expectations, but its weight-loss pill Orforglipron shows 11% weight loss and 24% dropout rate at highest dose, weighing on shares.

-- #AnjaleeKhemlani #AngeliCamalani #DaveRicks #EvanSeegerman #business

Loading quoted post…

Anjalee Khemlani Angeli Camalani Dave Ricks Evan Seegerman business mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqp9rg774jhzs4rw4wmejypedptl3pk34wz80hdxxnjghy2amm8qxsgsxa5t

ELI LILLY SECOND QUARTER EARNINGS BEAT ON STRONG GLP-1 SALES, BUT STOCK DIVES ON GLP-1 PILL TRIAL RESULTS

https://s.yimg.com/ny/api/res/1.2/MwywwZOTU4FpEEiAYybdaw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2025-04/9f779d70-25ff-11f0-b6f7-9778a735cf34

✍️ Eli Lilly reported better-than-expected earnings for the second quarter, but its oral GLP-1 pill failed to meet expectations, causing the stock to drop 13%.

-- #DaveRicks #JaredHolz #AnjaleeKhemlani #business

Loading quoted post…

Dave Ricks Jared Holz Anjalee Khemlani business mainstream:perspective

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqf3jd5s7adgjwfjhglg97syl3ycsnsen6cvnaju47r3csrn72edls9cqdsg

ELI LILLY BEATS EARNINGS FOR SECOND QUARTER ON STRONG GLP-1 SALES, BUT STOCK DIVES ON GLP-1 PILL TRIAL RESULTS

https://s.yimg.com/ny/api/res/1.2/MwywwZOTU4FpEEiAYybdaw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2025-04/9f779d70-25ff-11f0-b6f7-9778a735cf34

✍️ Eli Lilly reported better-than-expected earnings for the second quarter, driven by strong sales of its GLP-1s, but its oral pill GLP-1, orforglipron, disappointed in late-stage trials.

-- #DaveRicks #JaredHolz #AnjaleeKhemlani #business

Loading quoted post…

Dave Ricks Jared Holz Anjalee Khemlani business mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq992pusdu2e3kpyjj7ytltfl5zfmht2g8efdp2f7v7eltvg5vvgvq3g4qtx

CAN ELI LILLY STOCK WITHSTAND THE THREAT OF PRESIDENT TRUMP'S NEW SWEEPING TARIFFS?

https://s.yimg.com/ny/api/res/1.2/T.P6dcpe2sLRBOnVcZWnZQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/0335549b1e002a7277f6e7305a63eb91

✍️ President Trump has threatened to impose tariffs of up to 200% on pharmaceutical imports, which could negatively affect Eli Lilly's margins. However, the company's CEO believes the impact will be temporary.

-- #PresidentTrump #DaveRicks #HowardLutnick #UnitedStates #Ireland #business

Loading quoted post…

President Trump Dave Ricks Howard Lutnick United States Ireland business mainstream:perspective

7/19/2025

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqs4fyxy5rh6a9zw064kkatkjnk5twq7fdt0u0706q89ath4yt50tsujmntc

NOVO NORDISK IS BETTING ON A CEO SHAKEUP TO REGAIN ITS WEIGHT LOSS DRUG EDGE OVER ELI LILLY

https://image.cnbcfm.com/api/v1/image/107384912-17099193952024-03-08t163656z_688503029_rc2nh6akn9wi_rtrmadp_0_novo-nordisk-strategy.jpeg?v=1709919495&w=1920&h=1080

✍️ Novo Nordisk's CEO steps down as the company struggles to regain its lead in the weight loss drug market, with Eli Lilly's rival treatment gaining ground.

-- #LarsFruergaardJorgensen #DaveRicks #EvanSeigerman #CourtneyBreen #HelgeLund #Copenhagen #Denmark #UnitedStates #health

Loading quoted post…

Lars Fruergaard Jorgensen Dave Ricks Evan Seigerman Courtney Breen Helge Lund Copenhagen Denmark United States

5/19/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqulhut4lakuvyfct2gqa6036xfgdlrcqm8y0c5jejg4mnxhnwfskqpwhul4

JIM CRAMER SAYS ELI LILLY AND COMPANY (LLY) CEO DAVID RICKS IS ‘VERY CONSERVATIVE’

https://s.yimg.com/ny/api/res/1.2/UjoPACeXPFyN.4G.yM_TTw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/860932d32d923713fdffa5b1d444d8a3

✍️ Jim Cramer discusses AI and its impact on the stock market, mentioning Eli Lilly and Company (NYSE:LLY) as one of his favorite pharmaceutical and healthcare stocks.

-- #JimCramer #DavidFaber #DaveRicks #JensenHuang #China #UnitedStates #EU #Iceland #Mexico #technology

Loading quoted post…

Jim Cramer David Faber Dave Ricks Jensen Huang China United States EU Iceland

5/7/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqpgzsx62kmzlwgfrz42qcfnnv05hrzplrqr6n4934qnhlx53wevnqra6xmc

ELI LILLY DOWNPLAYS CVS MOVE TO DROP ZEPBOUND COVERAGE, SHARES PLUNGE

https://media.zenfs.com/en/reuters-finance.com/d24b443d01b743295bfe04b1025ecb1e

✍️ Eli Lilly's shares fell 10% after CVS Health decided to drop the company's obesity drug Zepbound from some lists of medicines it covers for reimbursement.

-- #DaveRicks #DavidJoyner #DanielBarasa #DavidRisinger #Bengaluru #NewYork #business

Loading quoted post…

Dave Ricks David Joyner Daniel Barasa David Risinger Bengaluru New York business mainstream:perspective

5/2/2025

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqk68lez9ne24sx7tk3sd6ce023ewwda7w6jf2assu5hcg6xtferks2frsth

ELI LILLY CEO SAYS COMPANY CAN HELP 'RESPOND' TO NATIONAL SECURITY CONCERNS AROUND ESSENTIAL DRUGS AS TARIFFS LOOM

https://image.cnbcfm.com/api/v1/image/108139274-1746103037690-gettyimages-2078688905-yale390482_nqf77adz.jpeg?v=1746103055&w=1920&h=1080

✍️ Eli Lilly CEO Dave Ricks expressed concerns about national security concerns around cheaper essential medicines and the potential impact of pharmaceutical tariffs on the industry.

-- #DaveRicks #DonaldTrump #AlbertBourla #NewYorkCity #India #China #Ireland #Singapore #Switzerland #US #business

Loading quoted post…

Dave Ricks Donald Trump Albert Bourla New York City India China Ireland Singapore

5/1/2025

npub1hyh2zn8…ncvnzp

WEIGHT-LOSS CRAZE SPARKS A DC LOBBYING BONANZA

https://static.politico.com/1a/26/65e46c854517b7ed3036787de74d/main-lippman-weightlossdrugs-illustration.jpg

✍️ President Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare should cover them, with pharma companies and telehealth platforms lobbying for their interests.

-- #DonaldTrump #RobertF.KennedyJr. #SeanSpicer #MehmetOz #ElonMusk #DaveRicks #GregD'Angelo #Washington #Europe #health

Loading quoted post…

nostr:nevent1qvzqqqqqqypzpwfw59x0wkzthr52tx7k4su4gfmzuedhgsue5cdfev7pe7qxqmrhqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqthlpw6que4fe8cztpjfexza8pung55k3e42pw77k56j0wcqu77gsuw7azj

Donald Trump Robert F. Kennedy Jr.Sean Spicer Mehmet Oz Elon Musk Dave Ricks Greg D'Angelo Washington

4/27/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqt42aeln85y78nkeujawq2t8d0ms3nhwwgqznpvz7080defxcke3qj3nlpv

ANALYSIS-PHARMA COMPANIES EXPECTED TO ABSORB ANY TARIFF HIT IN SHORT TERM

https://media.zenfs.com/en/reuters-finance.com/db3453d8c7ca463c4dcab71f62447088

✍️ The US tariffs on pharmaceuticals may lead to higher prices for brand-name medicines, but in the short term, the costs are likely to be absorbed by drugmakers rather than patients.

-- #DeenaBeasley #MelissaBarber #RobinFeldman #BillCoyle #DaveRicks #WilliamPadula #US #YaleUniversity #India #China #EuropeanUnion #Ireland #UnitedStates #health

Loading quoted post…

Deena Beasley Melissa Barber Robin Feldman Bill Coyle Dave Ricks William Padula US Yale University

4/16/2025

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq4udj6hvxjta2jlm5k6t8d6frfeacx48ptje6n43862azjqvqzhmsnm7pca

TRUMP'S PHARMACEUTICAL TARIFFS COULD RAISE COSTS FOR PATIENTS, WORSEN DRUG SHORTAGES

https://image.cnbcfm.com/api/v1/image/105349029-1532439541748gettyimages-501415374.jpeg?v=1743629970&w=1920&h=1080

✍️ President Trump's planned tariffs on pharmaceuticals could disrupt the global supply chain, drive up drug prices, and exacerbate shortages of critical medicines, experts warn.

-- #DonaldTrump #MarianaSocal #SteveScala #ArdaUral #MartaWosińska #DaveRicks #UnitedStates #Europe #China #India #health

Loading quoted post…

Donald Trump Mariana Socal Steve Scala Arda Ural Marta Wosińska Dave Ricks United States Europe

4/11/2025